1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. ELICIO THERAPEUTICS INC.

Elicio Therapeutics Inc.

XNAS: ELTX

Download real time

7.75 -0.15 (-1.90%)

32.31% Fall from 52W High

40,802 XNAS Volume

XNAS 14 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
13S
7W
0O
3T
122.9

Market Cap

Below industry Median
-2.6

PE TTM

Negative PE TTM
0.1

PEG TTM

PEG TTM is less than 1
-4.9

Price to Book

Negative Price to Book
-0.2

Beta 1Year

Very Low volatility


Insider Trading disclosures for Elicio Therapeutics Inc.

The latest disclosure was made by Yekaterina Chudnovsky in Elicio Therapeutics Inc. where a trade of 3,442,341 Convertible Note (convertible into Common Stock) done was reported to US exchanges on March 5, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Yekaterina Chudnovsky Director, Ten Percent Owner 05 Mar 2025 3,442,341 0 - - Convertible Note (convertible into Common Stock)
Yekaterina Chudnovsky Director, Ten Percent Owner 05 Mar 2025 3,500,573 5,416,212 - 5.8 20,338,329 Common Stock
Peter DeMuth Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 44,400 44,400 - - Stock Option (Right to Buy)
Robert Connelly Director, CEO, President and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 121,600 121,600 - - Stock Option (Right to Buy)
Christopher Haqq See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 44,000 44,000 - - Stock Option (Right to Buy)
Peter DeMuth Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.41 per share. 16 Dec 2024 381 381 - 4.4 1,680 Common Stock
Peter DeMuth Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Dec 2024 381 0 - - Stock Option (Right to Buy)
Jay R. Venkatesan Director 26 Nov 2024 50,000 179,581 - 0.0 500 Common Stock
Jay R. Venkatesan Director 26 Nov 2024 50,000 0 - - Warrant to Purchase Common Stock
Yekaterina Chudnovsky Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Nov 2024 4,100 4,100 - - Stock Option (Right to Buy)
Carol Gail Ashe Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Nov 2024 4,100 4,100 - - Stock Option (Right to Buy)
Jay R. Venkatesan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Nov 2024 4,100 4,100 - - Stock Option (Right to Buy)
Allen R. Nissenson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Nov 2024 4,100 4,100 - - Stock Option (Right to Buy)
Karen J. Wilson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Nov 2024 4,100 4,100 - - Stock Option (Right to Buy)
Robert R. Ruffolo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Nov 2024 4,100 4,100 - - Stock Option (Right to Buy)
Julian Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Nov 2024 4,100 4,100 - - Stock Option (Right to Buy)
Peter DeMuth Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 29,800 29,800 - - Stock Option (Right to Buy)
Robert Connelly Director, CEO, President and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 91,600 91,600 - - Stock Option (Right to Buy)
Christopher Haqq See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2024 28,200 28,200 - - Stock Option (Right to Buy)
Yekaterina Chudnovsky Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Aug 2024 3,442,341 3,442,341 - - Convertible Note (convertible into Common Stock)
Jay R. Venkatesan Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Jun 2024 50,000 50,000 - - Pre-Funded Warrants
Jay R. Venkatesan Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Jun 2024 50,000 50,000 - - Common Warrants
Yekaterina Chudnovsky Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Jun 2024 1,600,000 1,600,000 - - Common Warrants
Yekaterina Chudnovsky Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Jun 2024 1,600,000 1,600,000 - - Pre-Funded Warrants
Jay Venkatesan Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Jun 2024 50,000 50,000 - - Common Warrants
Jay Venkatesan Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Jun 2024 50,000 50,000 - - Pre-Funded Warrants
Jay Venkatesan Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Jun 2024 50,000 50,000 - - Common Warrants
Jay Venkatesan Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Jun 2024 50,000 50,000 - - Pre-Funded Warrants
Jay Venkatesan Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Jun 2024 50,000 50,000 - - Common Warrants
Jay Venkatesan Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Jun 2024 50,000 50,000 - - Pre-Funded Warrants
Jay Venkatesan Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Jun 2024 50,000 50,000 - - Common Warrants
Jay Venkatesan Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 28 Jun 2024 50,000 50,000 - - Pre-Funded Warrants
Yekaterina Chudnovsky Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 Mar 2024 1,032,702 1,032,702 - - Pre-Funded Common Stock Purchase Warrant
DeMuth Peter Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 29,800 29,800 - - Stock Option (right to buy)
Connelly Robert Director, CEO, President and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 225,137 225,137 - - Stock Option (right to buy)
Peter DeMuth Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 342 342 - - Stock Option (right to buy)
Haqq Christopher See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 28,200 28,200 - - Stock Option (right to buy)
Piekos Brian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2024 43,225 43,225 - - Stock Option (right to buy)
Ashe Carol Gail Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Dec 2023 4,100 4,100 - - Stock Option (right to buy)
Ruffolo Robert R. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Dec 2023 4,100 4,100 - - Stock Option (right to buy)
Nissenson Allen R. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Dec 2023 4,100 4,100 - - Stock Option (right to buy)
Chudnovsky Yekaterina Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Dec 2023 4,100 4,100 - - Stock Option (right to buy)
Venkatesan Jay Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Dec 2023 4,100 4,100 - - Stock Option (right to buy)
Adams Julian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Dec 2023 4,100 4,100 - - Stock Option (right to buy)
Yekaterina Chudnovsky Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 5.81 per share. 22 Dec 2023 1,213,000 1,915,639 - 5.8 7,047,530 Common Stock
Brian Piekos Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 75,484 75,484 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters